Bakkt Holdings, Inc. Quarterly Depreciation in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bakkt Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q3 2024.
  • Bakkt Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, a 92.9% decline year-over-year.
  • Bakkt Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.7M, a 66.7% decline year-over-year.
  • Bakkt Holdings, Inc. annual Depreciation for 2023 was $5.1M, a 45.7% increase from 2022.
  • Bakkt Holdings, Inc. annual Depreciation for 2022 was $3.5M.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.7M $100K -$1.3M -92.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $3M $100K -$1.2M -92.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $4.2M $100K -$900K -90% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.1M $1.4M $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $5.1M $1.4M +$500K +55.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $4.6M $1.3M +$600K +85.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $4M $1M +$500K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.5M $1.4M +$600K +75% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $2.9M $900K Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-02-14
Q2 2022 $700K -$700K -50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $500K -$600K -54.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $800K Oct 15, 2021 Dec 31, 2021 10-K 2023-03-24
Q2 2021 $1.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.